Cannabinoid receptor 2 (CB2) agonists and antagonists: a patent update

Area of Science:

• Pharmacology
• Medicinal Chemistry
• Drug Discovery

Background:

• The CB2 receptor is a promising target for therapeutic interventions.
• Modulation of CB2 receptors shows potential for treating pain, inflammation, arthritis, addictions, and cancer.
• CB2 receptor modulation is associated with a lack of central side effects.

Purpose of the Study:

• To review novel scaffolds for CB2 receptor ligands.
• To highlight diverse therapeutic applications of CB2 modulators.
• To analyze patent literature published since 2012.

Main Methods:

• Literature review of patents.
• Analysis of novel CB2 ligand scaffolds.
• Evaluation of therapeutic applications for CB2 modulators.

Main Results:

• Significant structural diversity in CB2 modulator scaffolds was identified in patent literature.
• Several CB2 agonists have progressed to Phase II clinical trials for pain and inflammation.
• The patent landscape demonstrates a broad interest in CB2 receptor modulation.

Conclusions:

• The structural diversity of CB2 modulator scaffolds is a key feature of recent patent literature.
• CB2 agonists show promise in clinical development for pain and inflammation.
• Further exploration of CB2 modulators for neuroprotection and neurodegeneration is warranted.